The new NICE guideline enables us to individualise care bearing in mind the needs of the person in front of us. It is concerned with clinical efficacy, and – for once – the cost of care has not noticeably influenced its recommendations. In contrast, QOF does the exact opposite, demanding that we drive our patients’ HbA1c down to low […]
A commentary on the NICE guideline on identification and management of familial hypercholesterolaemia
Making sense of triglycerides
Antibiotic prophylaxis against infective endocarditis
Navigating the new NICE guideline on type 2 diabetes: Finding the best treatment pathway for each patient
Chronic kidney disease: Helping practices to identify patients at risk and reduce progression
Chronic kidney disease (CKD) has moved rapidly up the healthcare agenda over the last few years. It has shifted from being considered as a rather nebulous condition of interest mainly to nephrologists to the front line of chronic disease detection and prevention in primary care as part of integrated management of vascular risk. In fact, […]
